Overview

Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
To compare intraocular pressure lowering effectiveness of a new fixed combination drug.
Phase:
Phase 2
Details
Lead Sponsor:
Laboratorios Sophia S.A de C.V.
Treatments:
Brimonidine Tartrate
Dorzolamide
Timolol